The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 5, 2000, Pages 1281-1285

  Nguyen, Linh N ^a   Ha, Chul S ^a   Hess, Mark ^a   Romaguera, Jorge E ^a   Manning, John T ^a   Cabanillas, Fernando ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Combined modality treatment; Lymphoma; Mediastinal large B cell lymphoma; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MANTLE FIELD RADIOTHERAPY; MEDIASTINUM TUMOR; MEDICAL RECORD; MULTIMODALITY CANCER THERAPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION FIELD; RELAPSE; RETROSPECTIVE STUDY; SARCOMA; SECOND CANCER; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034662074     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00563-0     Document Type: Article

References (21)

1. Patchefsky A., Brodousky H., Menduke H., et al. Non-Hodgkin's lymphomas A clinico-pathologic sudy of 293 cases . Cancer. 34:1974;1173-1186.
2. Jones S., Fuks Z., Bull M., et al. Non-Hodgkin's lymphoma. IV. Clinico-pathologic correlation in 405 cases. Cancer. 31:1973;806-823.
3. Levitt L., Aisenberg A., Harris N., et al. Primary non-Hodgkin's lymphoma of the mediastinum. Cancer. 50:1982;2486-2492.
4. Lichtenstein A., Levine A., Taylor C., et al. Primary mediastinal lymphoma in adults. Am J Med. 68:1980;509-514.
5. Harris N., Jaffe E., Stein H., et al. A revised European-American classification of lymphoid neoplasms A proposal from the International Lymphoma Study Group . Blood. 84:1994;1361-1392.
6. Glick J., Kim K., Earle J., et al. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL). Proc Am Soc Clin Oncol. 14:1995;391.
7. Miller T., Dahlberg S., Cassady J., et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 339:(1):1998;21-26.
8. Shipp M., Harrington D., Anderson J. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 329:1993;987-994.
9. Rodriguez J., Cabanillas F., MacLaughlin P., et al. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the "tumor score. " Ann Oncol. 3:1992;711-717.
10. Rodriguez J., Pugh W., Romaguera J., et al. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low B2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase. Ann Oncol. 5:1994;847-849.
11. Fisher R., Gaynor E., Dahlberg S. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 14:1993;1002-1006.
12. Fuller L., Krasin M., Velasquez W. Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-BLEO and radiation. Int J Radiat Oncol Biol Phys. 32:1995;3-11.
13. Swan F., Velasquez W., Fuller L. Successful outcome of patients (PTS) with good risk large cell lymphoma (LCL) with a shortened schedule of treatment (RX). (Abstr.) Proc Am Soc Clin Oncol. 10:1991;273.
14. Cabanillas F., McLaughlin P., Hagemeister F., et al. Improvement in survival and disease free survival of intermediate grade and immunoblastic lymphomas treated with the novel ATT regimen. (Abstr.) Proc Am Soc Clin Oncol. 13:1994;338.
15. Abou-Elella A., Weisenburger D., Vose J., et al. Primary mediastinal large B-cell lymphoma A clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group . J Clin Oncol. 17:(3):1999;784-790.
16. Ulusakarya A., Koscielny S., Vantelon J., et al. Primary mediastinal diffuse large cell lymphoma in 119 patients of a single institution Prognostic features and role of radiotherapy . Proc Am Soc Clin Oncol. 18:1999;15a.
17. Popat B., Przepiord D., Champlin R., et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma Mediastinal localization predicts for a favorable outcome . J Clin Oncol. 16:1998;63-69.
18. Lavabre-Betrand T., Donadio D., Fegueux N., et al. A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer. 69:1992;2561-2566.
19. Addis B., Isaacson P. Large cell lymphoma of the mediastinum B cell tumor of probable thymic origin . Histopathology. 10:1986;379-390.
20. Zinzani P., Bendandi M., Frezza G., et al. Primary mediastinal B-cell lymphoma with sclerosis Clinical and therapeutic evaluation of 22 patients . Leuk Lymphoma. 21:1996;311-316.
21. Cazals-Hatem D., Lepage E., Brice P., et al. Primary mediastinal large B-cell lymphoma. Am J Surg Pathol. 20:(7):1996;877-888.